Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.46 CHF | +1.54% | +0.44% | +5.38% |
05-06 | NOVARTIS AG : UBS maintains a Buy rating | ZD |
05-02 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.38% | 199B | |
+31.52% | 690B | |
+25.04% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+14.04% | 235B | |
-9.90% | 195B | |
+3.98% | 161B | |
-2.19% | 159B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis : lung cancer drug fails another Phase III trial